83 related articles for article (PubMed ID: 7128701)
1. Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.
Hirschhorn ID; Makman MH
Eur J Pharmacol; 1982 Sep; 83(1-2):61-7. PubMed ID: 7128701
[TBL] [Abstract][Full Text] [Related]
2. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
List SJ; Wreggett KA; Seeman P
J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat.
Hirschhorn ID; Makman MH; Sharpless NS
Brain Res; 1982 Feb; 234(2):357-68. PubMed ID: 7199364
[TBL] [Abstract][Full Text] [Related]
4. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
Bradbury AJ; Costall B; Naylor RJ
J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
[TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]ADTN to rat striatal membranes.
Templeton WW; Woodruff GN
Biochem Pharmacol; 1982 Apr; 31(8):1629-32. PubMed ID: 6124259
[TBL] [Abstract][Full Text] [Related]
6. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
7. Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions.
Hirschhorn ID; Makman MH; Gardner EL
Eur J Pharmacol; 1980 Mar; 62(1):123-4. PubMed ID: 6154585
[No Abstract] [Full Text] [Related]
8. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
Mulder TB; Grol CJ; Dijkstra D; Horn AS
Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
[TBL] [Abstract][Full Text] [Related]
9. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
10. Changes in (3H)-ADTN binding to microsomal and synaptic membrane fractions from rat striata following kainic acid lesions.
Davis A; Woodruff GN; Poat JA; Freedman SB
Biochem Pharmacol; 1980 Jun; 29(12):1645-8. PubMed ID: 7406893
[No Abstract] [Full Text] [Related]
11. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
Clement-Cormier Y; Abel M
Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
[TBL] [Abstract][Full Text] [Related]
12. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
Westerink BH; Dijkstra D; Feenstra MG; Horn AS; Rollema H
Eur J Pharmacol; 1980 Jun; 64(2-3):115-21. PubMed ID: 7398758
[TBL] [Abstract][Full Text] [Related]
13. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
Sanvarinda Y; Phivthongngam L; Govitrapong P
Neurochem Int; 1998 Aug; 33(2):187-93. PubMed ID: 9761463
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
[TBL] [Abstract][Full Text] [Related]
15. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
Robertson HA
Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
[TBL] [Abstract][Full Text] [Related]
16. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
Roger LJ; Breese GR; Morell P
Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
[TBL] [Abstract][Full Text] [Related]
17. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
Osborne NN
Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
[TBL] [Abstract][Full Text] [Related]
18. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
Rollema H; Feenstra MG; Grol CJ; Lewis MH; Staples L; Mailman RB
Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):338-45. PubMed ID: 3736679
[TBL] [Abstract][Full Text] [Related]
19. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
20. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
Thal LJ; Horowitz SG; Dvorkin B; Makman MH
Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
